George Soros is a Hungarian-American billionaire and businessman who launched Soros Fund Management in 1970. Soros Fund Management, which is now a family office, was created as a hedge fund in New York for managing money for clients. George Soros has a Q2 stock portfolio worth $5.6 billion, compared to $6.6 billion in the prior quarter. Soros’ investment philosophy consists of watching the currency swings and commodity prices closely, in addition relying on macro and market analysis. He is also involved heavily in American politics.
The 13F filings for the second quarter of 2022 reveal that Soros Fund Management acquired 49 new stocks, made additional purchases in 43 stocks, sold out of 51 securities, and reduced holdings in 18 equities. The fund’s investments are concentrated in the real estate, communications, finance, healthcare, consumer discretionary, and information technology sectors. Some of the top stock picks of George Soros include $Rivian Automotive, Inc.(RIVN)$, $Amazon.com(AMZN)$ and $D.R. Horton(DHI)$.
$Salesforce.com(CRM)$
Soros Fund Management’s Stake Value: $103,564,000
Salesforce is a California-based company offering customer relationship management technology to companies and individuals worldwide. Soros Fund Management boosted its Salesforce, Inc. stake by 139% in Q2 2022, holding 627,509 shares worth $103.5 million. Salesforce, Inc. is one of the top stock picks from the George Soros stock portfolio.
On November 2, Macquarie analyst Sarah Hindlian-Bowler took over coverage of Salesforce, Inc. with an Outperform rating and a $210 price target. The analyst believes the shares are undervalued and expects Salesforce, Inc. to end its multiple contraction with growth and margins supported by its Cloud Suite.
$Alphabet(GOOG)$
Soros Fund Management’s Stake Value: $115,882,000
Alphabet has been part of the George Soros stock portfolio since the last quarter of 2015, with minor breaks over the years. In the second quarter of 2022, Soros held 1.06 million shares of Alphabet worth $115.8 million, representing 2.06% of the total holdings.
On October 27, Alphabet announced that it had acquired AI avatar startup Alter for about $100 million. Alter helps creators and brands develop and express their virtual identity. The AI startup will enable Alphabet to improve and advance its content offerings.
Oppenheimer analyst Jason Helfstein on October 26 maintained an Outperform rating on Alphabet but trimmed the price target on the shares to $135 from $155 to reflect lower 2023 estimates on softer first half of the year and slower headcount growth.
$Biohaven Pharmaceutical Holding Co Ltd.(BHVN)$
Soros Fund Management’s Stake Value: $182,866,000
Biohaven is a Connecticut-based clinical-stage biopharmaceutical company, focused on discovering and developing therapies for neurological and neuropsychiatric diseases in the United States. Biohaven was a new addition to the George Soros stock portfolio in Q2 2022, with the hedge fund buying 1.25 million shares worth $182.8 million, representing 3.25% of the total 13F securities.
On October 21, Biohaven priced an upsized public offering of 25 million of its common shares, at a public offering price of $10.50 per common share. The offering closed on October 25, and the company expects to use the net proceeds received for general corporate purposes.
Cowen analyst Ken Cacciatore on November 7 maintained an Outperform rating on Biohaven but slashed the firm's price target on the shares to $25 from $165 following its spin off. The analyst said the target is based mainly on BHV-7000 in epilepsy, but there is a potential for upside via the emerging pipeline.
Comments